Sanofi India jumped 7.04% to Rs 4,495 at 12:56 IST on BSE after the company reported an impressive growth in bottom line in Q2 September 2017.
Meanwhile, the S&P BSE Sensex was up 416.81 points or 1.25% at 33,629.94.
On the BSE, 4,787 shares were traded on the counter so far as against average daily volumes of 148 shares in the past two weeks. The stock had hit a high of Rs 4,785 and a low of Rs 4,344 so far during the day.
Sanofi India's net profit rose 40.28% to Rs 116.30 crore on 4.99% growth in gross sales (inclusive of excise duty) to Rs 626.60 crore in Q2 September 2017 over Q2 September 2016. The result was announced after market hours yesterday, 31 October 2017.
Gross sales for the quarter (Q2 September 2017) are not comparable with year ago figures due to the implementation of Goods and Services (Tax) with effect from 1 July 2017.
Sales (excluding GST/excise duty) for the quarter increased 8% over a year ago.
Sanofi India is engaged in the manufacture and sale of pharmaceutical products.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
